Takeda Pharmaceutical to Cut Sales Jobs In Japan

Takeda Pharmaceutical Co is looking to cut sales jobs in Japan in its latest restructuring effort, as it overhauls domestic business following its $59 billion purchase (45.67 billion pounds) of Shire Plc, sources familiar with the company’s plans said, Reuters reported. Major pharma companies in Japan have scaled down their sales forces to cope with a shrinking market and cuts in drug prices imposed by the national health system. The layoffs by Takeda, Japan’s biggest drug maker, will be focused on sales positions, two industry sources told Reuters requesting anonymity to protect professional obligations. Takeda wants to reduce its ranks of medical representatives, who promote drugs to doctors and hospitals, and rely more on contract sales organisations to improve flexibility, said one of the people. Neither source had an estimate for the number of job cuts nor the timing. Read more